131 related articles for article (PubMed ID: 30707857)
21. Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).
Watterson E; Spitzer A; Watterson LR; Brackney RJ; Zavala AR; Olive MF; Sanabria F
Behav Brain Res; 2016 Oct; 312():333-40. PubMed ID: 27363925
[TBL] [Abstract][Full Text] [Related]
22. Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats.
Arnold HM; Nelson CL; Sarter M; Bruno JP
Psychopharmacology (Berl); 2003 Feb; 165(4):346-58. PubMed ID: 12454730
[TBL] [Abstract][Full Text] [Related]
23. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
Zaniewska M; McCreary AC; Stefański R; Przegaliński E; Filip M
Synapse; 2008 Dec; 62(12):935-9. PubMed ID: 18798299
[TBL] [Abstract][Full Text] [Related]
24. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Biala G; Staniak N
Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
[TBL] [Abstract][Full Text] [Related]
25. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
Celik E; Uzbay IT; Karakas S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
[TBL] [Abstract][Full Text] [Related]
26. Standardized Passiflora incarnata L. Extract Reverts the Analgesia Induced by Alcohol Withdrawal in Rats.
Schunck RVA; Macedo IC; Laste G; de Souza A; Valle MTC; Salomón JLO; Nunes EA; Campos ACW; Gnoatto SCB; Bergold AM; Konrath EL; Dallegrave E; Arbo MD; Torres ILS; Leal MB
Phytother Res; 2017 Aug; 31(8):1199-1208. PubMed ID: 28568647
[TBL] [Abstract][Full Text] [Related]
27. Does nicotine modify the psychotoxic effect of methamphetamine? Assessment in terms of locomotor sensitization in mice.
Kuribara H
J Toxicol Sci; 1999 Feb; 24(1):55-62. PubMed ID: 10073337
[TBL] [Abstract][Full Text] [Related]
28. Nicotine produces chronic behavioral sensitization with changes in accumbal neurotransmission and increased sensitivity to re-exposure.
Morud J; Adermark L; Perez-Alcazar M; Ericson M; Söderpalm B
Addict Biol; 2016 Mar; 21(2):397-406. PubMed ID: 25581387
[TBL] [Abstract][Full Text] [Related]
29. The mammalian target of rapamycin pathway in the basolateral amygdala is critical for nicotine-induced behavioural sensitization.
Gao Y; Peng S; Wen Q; Zheng C; Lin J; Tan Y; Ma Y; Luo Y; Xue Y; Wu P; Ding Z; Lu L; Li Y
Int J Neuropsychopharmacol; 2014 Nov; 17(11):1881-94. PubMed ID: 24916432
[TBL] [Abstract][Full Text] [Related]
30. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
Eggan BL; McCallum SE
Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
[TBL] [Abstract][Full Text] [Related]
31. The sedative activity of flavonoids from Passiflora quadrangularis is mediated through the GABAergic pathway.
Gazola AC; Costa GM; Zucolotto SM; Castellanos L; Ramos FA; de Lima TCM; Schenkel EP
Biomed Pharmacother; 2018 Apr; 100():388-393. PubMed ID: 29454287
[TBL] [Abstract][Full Text] [Related]
32. Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats.
Franke RM; Belluzzi JD; Leslie FM
Psychopharmacology (Berl); 2007 Nov; 195(1):117-24. PubMed ID: 17653695
[TBL] [Abstract][Full Text] [Related]
33. Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats.
Kelsey JE; Beer T; Lee E; Wagner A
Psychopharmacology (Berl); 2002 Jun; 161(4):370-8. PubMed ID: 12073164
[TBL] [Abstract][Full Text] [Related]
34. Hepatic, gastric, and intestinal first-pass effects of vitexin in rats.
Xue HF; Ying ZM; Zhang WJ; Meng YH; Ying XX; Kang TG
Pharm Biol; 2014 Aug; 52(8):967-71. PubMed ID: 24555505
[TBL] [Abstract][Full Text] [Related]
35. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.
Wooters TE; Neugebauer NM; Rush CR; Bardo MT
Neuropsychopharmacology; 2008 Apr; 33(5):1137-48. PubMed ID: 17581534
[TBL] [Abstract][Full Text] [Related]
36. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Wing VC; Shoaib M
Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
[TBL] [Abstract][Full Text] [Related]
37. Behavioral sensitization to nicotine in female and male rats.
Ericson M; Norrsjö G; Svensson AI
J Neural Transm (Vienna); 2010 Sep; 117(9):1033-9. PubMed ID: 20694487
[TBL] [Abstract][Full Text] [Related]
38. Effects of nicotine on ethanol-induced locomotor sensitization: A model of neuroadaptation.
Gubner NR; Phillips TJ
Behav Brain Res; 2015 Jul; 288():26-32. PubMed ID: 25857831
[TBL] [Abstract][Full Text] [Related]
39. Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring.
Lacy RT; Brown RW; Morgan AJ; Mactutus CF; Harrod SB
Dev Neurosci; 2016; 38(3):171-185. PubMed ID: 27287203
[TBL] [Abstract][Full Text] [Related]
40. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
